Skip to main content

Table 4 Indications associated with the first antidepressant prescription

From: Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch database

Indication

Ages 5–11 (n = 2330)

Ages 12–17 (n = 30,701)

SSRI (n = 22,130)

TCA (n = 10,489)

Any antidepressant ages 5–17 (n = 33,031)

Any of the pre-specified indications

998 (42.8%)

16,974 (55.3%)

15,295 (69.1%)

2463 (23.5%)

17,972 (54.4%)

Anxiety

136 (5.8%)

4019 (13.1%)

3601 (16.3%)

508 (4.8%)

4155 (12.6%)

Attention deficit hyperactivity disorder

< 10

61 (0.2%)

50 (0.2%)

14 (0.1%)

66 (0.2%)

Autism

206 (8.8%)

1020 (3.3%)

1127 (5.1%)

90 (0.9%)

1226 (3.7%)

Depression

72 (3.1%)

12,558 (40.9%)

11,537 (52.1%)

936 (8.9%)

12,630 (38.2%)

Enuresis

642 (27.6%)

308 (1.0%)

73 (0.3%)

877 (8.4%)

950 (2.9%)

Neuropathic pain

< 10

104 (0.3%)

< 10

107 (1.0%)

113 (0.3%)

Obsessive compulsive disorder

53 (2.3%)

751 (2.4%)

774 (3.5%)

28 (0.3%)

804 (2.4%)

Phobias

< 10

260 (0.8%)

222 (1%)

40 (0.4%)

268 (0.8%)

Self-harm

10 (0.4%)

2948 (9.6%)

2715 (12.3%)

190 (1.8%)

2958 (9.0%)

  1. Includes indications recorded less than 1 year before or 6 months after the first antidepressant prescription. Individuals may be included in both SSRI and TCA categories and may have records of more than one indication. Counts less than 10 have been masked
  2. SSRI selective serotonin reuptake inhibitor, TCA tricyclic and related antidepressant, n number